Loading company…
Otolith Labs develops wearable prescription devices for treating vertigo and other vestibular conditions.
Founded in 2015 and based in Washington, DC, Otolith Labs develops prescription medical devices for vestibular disorders such as chronic vertigo. Its nVSM wearable applies calibrated mechanical stimulation to the vestibular system. In September 2022, the company raised USD 20 million in Series A funding from Morningside Venture Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in